Notably, our study revealed a remarkable increase in MHC-I molecules following STC2 knockdown in osteosarcoma cells, implying that STC2 may mediate immune response by downregulating the expression of MHC-I molecules on the surface of tumor cells. Here, STC2 is linked to neoplasm.